A Biomineralized Bifunctional Patient‐Friendly Nanosystem for Sustained Glucose Monitoring and Control in Diabetes

Abstract Regular blood glucose monitoring and control is necessary for people with type 1 or advanced type 2 diabetes, yet diagnosing and treating patients with diabetes in an accurate, sustained and patient‐friendly manner remains limited. Here, a glucose‐responsive bifunctional nanosystem (PGOxMns) is constructed via one‐pot biomineralisation of manganese dioxide with glucose oxidase and ε‐poly‐L‐lysine. Under hyperglycaemic conditions, the cascade reactions that occur when glucose interacts with PGOxMns can trigger the production of Mn(II), which enhances the magnetic resonance imaging signal. Simultaneously, manganese dioxide catalyses the decomposition of toxic hydrogen peroxide into oxygen, which also maintains glucose oxidase (GOx) activity. In an in vivo model of diabetes, PGOxMns is used to monitor glucose levels (0–20 mm) and allowed identification of diabetic mice via T₁‐weighted MRI. Furthermore, PGOxMns is found to have a high insulin‐loading capacity (83.6%), likely due to its positive charge. A single subcutaneous injection of insulin‐loaded nanosystem (Ins‐PGOxMns) into diabetic mice resulted in a rapid and efficient response to a glucose challenge and prolonged blood glucose level control (< 200 mg dL⁻¹) for up to 50 h. Overall, this proof‐of‐concept study demonstrates the feasibility of using biomineralised nanosystems to develop patient‐friendly strategies for glucose monitoring and control.